Latest AI and machine learning research in hepatitis for healthcare professionals.
Interferon (IFN) is a pivotal agent against hepatitis B virus (HBV) in clinic, but there is a lack of accurate biomarkers to predict the response to IFN therapy in patients with chronic hepatitis B (CHB). Our study aimed to investigate potential targets for IFN therapy and to explore the network of interactions associated with IFN response. MicroRNA (miRNA) (GSE29911) and messenger RNA (GSE27555) ...
Hepatitis C virus (HCV) infection represents a significant contributor to chronic liver disease on a global scale. The prompt identification and management of HCV are imperative in order to avert complications and to maintain control over the disease. Nowadays, medical decision support systems that incorporate advanced diagnostic methods and effective treatment strategies are of great importance i...
BACKGROUND & AIMS: Accurate prediction of disease severity and prognosis are challenging in patients with cirrhosis. We evaluated whether the deep lea...
Identifying viral replication within cells demands labor-intensive isolation methods, requiring specialized personnel and additional confirmatory test...
BACKGROUND: Early recognition of steatosis (fatty liver) and fibrosis in liver health is crucial for effectively managing and preventing the possibili...
Despite the significant success of vaccinations, increasing vaccine hesitancy poses a threat to public health, making effective vaccination communicat...
INTRODUCTION: Accurate prediction of immunogenic proteins is crucial for vaccine development and understanding host-pathogen interactions in bacterial...
Developments in ambulatory electrocardiogram (ECG) technology have led to vast amounts of ECG data that currently need to be interpreted by human tech...
BACKGROUND: Viral vaccines have been proven significant in protecting us against viral diseases such as COVID-19. To better understand and design vira...
Early diagnosis at the metabolomic level is crucial for the treatment of liver cirrhosis and hepatocellular carcinoma (HCC). In this study, attempts w...
BACKGROUND: Mumps is a viral respiratory disease characterized by facial swelling and transmitted through respiratory secretions. Despite the availabi...
BACKGROUND: Cirrhosis is a leading cause of mortality in patients with chronic liver disease (CLD). The rapid development of metabolomic technologies ...
Transient receptor potential vanilloid 4 (TRPV4) is a calcium-permeable cation channel critical for maintaining intracellular Ca homeostasis and is es...
The global impact of SARS-CoV-2 has highlighted the urgent need for novel antiviral therapies. This study integrates combinatorial chemistry, molecula...
BACKGROUND: The global prevalence of non-alcoholic fatty liver disease (NAFLD) is approximately 30%, and the condition can progress to non-alcoholic s...
The vaccinia virus (VV) is extensively utilized as a vaccine vector in the treatment of various infectious diseases, cardiovascular diseases, immunode...
Liver malignancies, particularly hepatocellular carcinoma (HCC), pose a formidable global health challenge. Conventional diagnostic techniques frequen...
BACKGROUND: Immune checkpoint inhibitors have proven efficacy against hepatitis B-virus positive hepatocellular. However, Immunotherapy-related advers...
A major histologic feature of cirrhosis is the loss of liver architecture with collapse of tissue and vascular changes per unit. We developed qVessel ...